World's Best Scientists 2026 revealed!
Christopher P. Conlon

Christopher P. Conlon

Christopher P. Conlon publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Christopher P. Conlon sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Christopher P. Conlon D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher P. Conlon sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

    M Voysey;S A Costa Clemens;S A Madhi;L Y Weckx

  • Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

    Y Peng;A J Mentzer;G Liu;G Liu;X Yao

  • HIV-Specific Cd8+T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

    Victor Appay;Douglas F. Nixon;Sean M. Donahoe;Geraldine M.A. Gillespie

  • Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.

    S F Lumley;D O'Donnell;N E Stoesser;P C Matthews

  • Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells.

    Ajit Lalvani;Ansar A. Pathan;Helen McSHANE;Robert J. Wilkinson

  • T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.

    K J Ewer;Barrett;S Belij-Rammerstorfer;H Sharpe

  • Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses

    Anthony D. Kelleher;Chad Long;Edward C Holmes;Rachel L. Allen

  • Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

    L Papagno;C A Spina;A Marchant;M Salio

  • Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.

    R P Payne;S Longet;J A Austin;D T Skelly

  • Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

    Barrett;S Belij-Rammerstorfer;C Dold;K J Ewer

  • A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

    Matilu Mwau;Inese Cebere;Julian Sutton;Priscilla Chikoti

  • Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study.

    D W Eyre;S F Lumley;D O'Donnell;M Campbell

  • The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers.

    S F Lumley;J Wei;D O'Donnell;N E Stoesser;N E Stoesser;N E Stoesser

  • Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers.

    Inese Cebere;Lucy Dorrell;Helen McShane;Alison Simmons

  • Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.

    D T Skelly;A C Harding;J Gilbert-Jaramillo;M L Knight

  • HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor

    T Dong;G Stewart-Jones;N Chen;P Easterbrook

  • Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome

    Rusung Tan;Xiaoning Xu;Graham S. Ogg;Pokrath Hansasuta

  • T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study.

    A Angyal;S Longet;S C Moore;R P Payne

  • Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients

    Y Peng;A J Mentzer;G Liu;G Liu;X Yao

  • Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine (preprint)

    Voysey, Merryn, Costa Clemens, Sue Ann, Madhi, Shabir A.;Weckx, Lily Yin, Folegatti, Pedro M.;Parvinder K. Aley;Angus, Brian John, Baillie, Vicky, Barnabas, Shaun L.

Frequent Co-Authors

Tao Dong
Tao Dong University of Oxford
Derrick W. Crook
Derrick W. Crook University of Oxford
Gavin R. Screaton
Gavin R. Screaton University of Oxford
Tim E. A. Peto
Tim E. A. Peto University of Oxford
Andrew J. McMichael
Andrew J. McMichael University of Oxford
Sarah Rowland-Jones
Sarah Rowland-Jones University of Sheffield
Philippa C. Matthews
Philippa C. Matthews University of Oxford
John Frater
John Frater University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Nicole Stoesser
Nicole Stoesser University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology in the USA opens doors to various specialized healthcare roles. For those interested in advancing their nursing career, exploring cheapest psych np programs online can offer cost-effective ways to specialize in psychiatric care.

Salary expectations vary by state, and for advanced practice roles like Doctor of Nursing Practice (DNP), understanding the dnp salary by state helps in making informed career decisions. This knowledge is crucial for budgeting education expenses and planning long-term investments.

Transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (NP) is another viable path for Immunology graduates seeking to work in more intensive healthcare settings. Resources on acute care certification for fnp provide guidance on acquiring the relevant credentials smoothly.

Accelerated programs can fast-track your credentials and help you enter the workforce quickly. Exploring accelerated nurse practitioner programs allows you to find options that fit your timeline and career goals.

Best Scientists Citing Christopher P. Conlon

Trending Scientists

Recently Published Articles